By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Immune Pharma Announces The Launch Of REMAIN, An International Overall Survival Study With Ceplene And Low Dose Proleukin In Remission Maintenance In Acute Myeloid Leukemia 2/17/2017 7:40:19 AM
Immune Pharma Appoints New Chairman Of The Board Of Directors 1/27/2017 7:02:22 AM
Immune Pharma Enters A Research Partnership To Develop Mono- And Bispecific Antibodies Against Novel Targets In The Tumor Microenvironment 1/23/2017 9:59:04 AM
Immune Pharma Release: Company Will Request An Appeal To Regain Compliance With Nasdaq's Minimum Bid Price Rule 1/10/2017 6:47:10 AM
Immune Pharma Announces Immuno-Oncology R&D Update On December 8, 2016 11/22/2016 10:19:07 AM
Immune Pharma Secures Up To $11 Million In New Financing To Be Deployed With A Focus On Bertilimumab Clinical Development 11/17/2016 10:14:03 AM
Immune Pharma Receives FDA Guidance For Low Dose IL-2 In Combination With Phase III Pivotal Trial Of Its AML Therapy Ceplene 10/27/2016 6:44:41 AM
Immune Pharma Announces Formation Of Management Team For Maxim Pharmaceuticals, Inc. (MAXM), Its Pain And Neurology Subsidiary 10/17/2016 11:02:16 AM
Immune Pharma Signs Agreement To Fund Maxim Pharmaceuticals, Inc. (MAXM), Its Pain And Neurology Subsidiary 9/16/2016 8:41:28 AM
Immune Pharma Receives $2 Million Investment In Common Stock At $0.50 Per Share 9/7/2016 9:31:11 AM
12345678910...
//-->